mg555娱乐娱城-金沙城娱乐中心网址

R&D

R & D and Innovation Drive the Company to Grow from Strength to Strength

Sinqi Ophthalmic Medications pursues innovation-driven growth and has a provincial-level enterprise technology center, a provincial-level ophthalmic medication engineering technology research center and a provincial-level child and adolescent myopia prevention and control engineering research center. It has also established an ophthalmic drug R & D platform for conventional ophthalmic preparations, instant gels, sustained-release preparations, compatibility testing for drug packaging materials, ophthalmic pharmacodynamics, pharmacokinetics, and toxicology, etc. It has developed a unique R&D system and has innovated in the forefront of ophthalmic medications.

研发中心-2.jpg

研发中心-3.gif

研发中心-4.jpg

mg555娱乐娱城|金沙城娱乐中心网址

XML 地图 | Sitemap 地图

mg555娱乐娱城|金沙城娱乐中心网址

XML 地图 | Sitemap 地图